Thromboprophylaxis following caesarean section: comparison of the anti-factor Xa activities of dalteparin, enoxaprin and tinzaparin.

被引：0
|
作者：
Ellison, J [1 ]
Thomson, AJ [1 ]
Walker, ID [1 ]
Greer, IA [1 ]
机构：
[1] Univ Glasgow, Glasgow Royal Infirm, Dept Obstet & Gynaecol, Glasgow G12 8QQ, Lanark, Scotland
来源：
BRITISH JOURNAL OF OBSTETRICS AND GYNAECOLOGY | 2000年 / 107卷 / 06期
关键词：
D O I：
暂无
中图分类号：
R71 [妇产科学];
学科分类号：
100211 ;
摘要：
引用
收藏
页码：823 / 823
页数：1
相关论文
共 50 条
  • [21] THE IMPORTANCE OF ANTI-FACTOR XA AND ANTITHROMBIN ACTIVITIES OF LOW-MOLECULAR-WEIGHT HEPARINS
    LANE, DA
    RYAN, K
    [J]. JOURNAL OF LABORATORY AND CLINICAL MEDICINE, 1990, 116 (02): : 269 - 270
  • [22] No accumulation of the peak anti-factor Xa activity of tinzaparin in elderly patients with moderate-to-severe renal impairment: the IRIS substudy
    Siguret, V.
    Gouin-Thibault, I.
    Pautas, E.
    Leizorovicz, A.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2011, 9 (10) : 1966 - 1972
  • [23] Dalteparin dose-dependently increases ROTEM® thrombelastography parameters only at supratherapeutic anti-factor Xa levels: An in vitro study
    Feuring, Martin
    Wehling, Martin
    Schultz, Armin
    [J]. CLINICAL AND EXPERIMENTAL PHARMACOLOGY AND PHYSIOLOGY, 2011, 38 (11) : 783 - 786
  • [24] MEDIAN TIME REQUIRED TO ACHIEVE THERAPEUTIC LEVELS OF ANTI-FACTOR XA IN CRITICALLY ILL CHILDREN RECEIVING DALTEPARIN: RETROSPECTIVE AUDIT
    Sharma, S.
    Ray, S.
    [J]. PEDIATRIC CRITICAL CARE MEDICINE, 2022, 23 (11)
  • [25] Effect of a dalteparin prophylaxis protocol using anti-factor Xa concentrations on venous thromboembolism in high-risk trauma patients
    Droege, Molly E.
    Mueller, Eric W.
    Besl, Kelly M.
    Lemmink, Jennifer A.
    Kramer, Elizabeth A.
    Athota, Krishna P.
    Droege, Christopher A.
    Ernst, Neil E.
    Keegan, Shaun P.
    Lutomski, Dave M.
    Hanseman, Dennis J.
    Robinson, Bryce R. H.
    [J]. JOURNAL OF TRAUMA AND ACUTE CARE SURGERY, 2014, 76 (02): : 450 - 456
  • [26] INFLUENCE OF VARIATIONS IN THE CHEMICAL-STRUCTURE OF HEPARIN ON ITS ANTI-COAGULANT AND ANTI-FACTOR XA ACTIVITIES
    AYOTTE, L
    LORMEAU, JC
    PERLIN, AS
    [J]. THROMBOSIS RESEARCH, 1981, 22 (1-2) : 97 - 102
  • [27] Should we be following anti-factor Xa levels in patients receiving prophylactic enoxaparin perioperatively?
    Pannucci, Christopher J.
    Rondina, Matthew T.
    [J]. SURGERY, 2017, 161 (02) : 329 - 331
  • [28] Anti-factor Xa Activity Is Not Associated With Venous Thromboembolism in Critically Ill Patients Receiving Enoxaparin for Thromboprophylaxis: A Retrospective Observational Study
    Dibiasi, Christoph
    Gratz, Johannes
    Wiegele, Marion
    Baierl, Andreas
    Schaden, Eva
    [J]. FRONTIERS IN MEDICINE, 2022, 9
  • [29] Twice daily enoxaparin, but not once daily dalteparin, is associated with elevated anti-factor Xa heparin levels at the time of epidural catheter removal.
    Douketis, J
    Crowther, MA
    [J]. BLOOD, 2001, 98 (11) : 707A - 707A
  • [30] Effect of the anti-factor Xa and anti-factor IIa activities of low-molecular-weight heparins upon the phases of thrombin generation (vol 5, pg 955, 2007)
    Gerotziafas, G. T.
    [J]. JOURNAL OF THROMBOSIS AND HAEMOSTASIS, 2007, 5 (06) : 1343 - 1343
12345